Skip to content
CNS Pulse
PipelineIndicationsCompaniesTargetsReadoutsConferencesAbstractsAuthors
  1. Home
  2. Pipeline
  3. Ulotaront (SEP-363856)
  4. ulotaront

Generic name (INN) · Small Molecule

ulotaront

ulotaront is a generic name (inn) for Ulotaront (SEP-363856), developed by Otsuka Pharmaceutical Co., Ltd..

Status
Phase 2/3 for Generalized anxiety disorder
Mechanism
TAAR1 Agonist
Developer
Otsuka Pharmaceutical Co., Ltd.

Programs

  • Ulotaront (SEP-363856) for Generalized anxiety disorderPhase 2/3Completed
  • Ulotaront (SEP-363856) for Major depressive disorderPhase 2/3Completed

Also known as

  • SEP-363856
  • SEP-856

View the full Ulotaront (SEP-363856) profile →

CNS Pulse

© 2026 CNS Pulse · Psychopharmacology pipeline intelligence & conference reports.